Danaher (NYSE:DHR) Upgraded at DZ Bank

by · The Markets Daily

Danaher (NYSE:DHR – Get Free Report) was upgraded by equities researchers at DZ Bank to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.

Other equities analysts also recently issued reports about the company. Evercore increased their target price on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday. Barclays dropped their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, TD Cowen dropped their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $235.14.

View Our Latest Report on DHR

Danaher Price Performance

Shares of DHR stock opened at $178.40 on Tuesday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market cap of $126.26 billion, a P/E ratio of 34.51, a P/E/G ratio of 2.35 and a beta of 0.81. The business has a fifty day simple moving average of $181.40 and a 200 day simple moving average of $206.59.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the company earned $1.88 EPS. Danaher’s revenue for the quarter was up 3.7% on a year-over-year basis. On average, sell-side analysts forecast that Danaher will post 8.43 EPS for the current fiscal year.

Institutional Investors Weigh In On Danaher

Institutional investors and hedge funds have recently made changes to their positions in the stock. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at about $26,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the fourth quarter valued at about $27,000. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the period. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at about $25,000. Finally, Main Street Group LTD acquired a new stake in shares of Danaher in the first quarter valued at about $25,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Danaher

(Get Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories